These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8143350)

  • 1. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
    Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
    Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fall of cardiac output in endotoxemic rats cannot explain all changes in organ blood flow: a comparison between endotoxin and low venous return shock.
    Mulder MF; van Lambalgen AA; van den Bos GC; Thijs LG
    Shock; 1996 Feb; 5(2):135-40. PubMed ID: 8705391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with hyperdynamic or hypodynamic circulation and role of platelet-activating factor in hemodynamic alterations in bacterial peritonitis in conscious rats.
    Novo C; Ais G; López-Farré A; Romeo JM; Pérez-Barriocanal F; López-Novoa JM
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):937-42. PubMed ID: 8606531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
    Sirén AL; Feuerstein G
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.
    Moore JM; Earnest MA; DiSimone AG; Abumrad NN; Fletcher JR
    Circ Shock; 1991 Sep; 35(1):53-9. PubMed ID: 1660355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
    Pons L; Droy-Lefaix MT; Braquet P; Buéno L
    Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
    Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
    J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat.
    Haglind E; Xia G; Rylander R
    Circ Shock; 1994 Feb; 42(2):83-91. PubMed ID: 8013065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats.
    Mulder MF; van Lambalgen AA; Huisman E; Visser JJ; van den Bos GC; Thijs LG
    Am J Physiol; 1994 Apr; 266(4 Pt 2):H1558-64. PubMed ID: 8184934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
    Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats.
    Kleber G; Braillon A; Gaudin C; Champigneulle B; Cailmail S; Lebrec D
    Gastroenterology; 1992 Jul; 103(1):282-8. PubMed ID: 1612334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
    Fletcher JR; DiSimone AG; Earnest MA
    Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of platelet-activating factor in conscious, normotensive endotoxemia.
    Ephgrave K; Kremer T; Broadhurst K; Cullen J
    J Surg Res; 1997 Mar; 68(2):170-4. PubMed ID: 9184676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional blood flow and metabolism in canine endotoxin shock before, during, and after infusion of glucose-insulin-potassium (GIK).
    Bronsveld W; van Lambalgen AA; van den Bos GC; Thijs LG; Koopman PA
    Circ Shock; 1986; 18(1):31-42. PubMed ID: 3510757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent effects of platelet-activating factor in the coronary circulation.
    Sagach VF; Zhukova AV; Braquet P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S85-9. PubMed ID: 1282996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.